Home-based transcranial electric stimulation (tDCS over M1 or tACS over DLPFC) improves quality of life in chronic pain patients compared to sham stimulation
In a double-blind RCT with 120 chronic pain participants, both active tES modalities (M1-tDCS and DLPFC-tACS) significantly improved quality of life compared to sham, with mean differences of -7.7 and -7.8 respectively (p<.001). However, no differential effects were found for symptom-specific domains like mood, fatigue, or sleep, and all groups showed increased physical activity and physical function improvements.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Home-based transcranial electric stimulation (tDCS over M1 or tACS over DLPFC) improves quality of life in chronic pain patients compared to sham stimulation The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 44/100 (low).
The Claim
Home-based transcranial electric stimulation (tDCS over M1 or tACS over DLPFC) improves quality of life in chronic pain patients compared to sham stimulation
This conclusion is most relevant to: 120 individuals with chronic pain (97 females, mean age 49.5 ± 8.7 years).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Transcranial electric stimulation in chronic pain: Effects on quality of life, physical function, activity and clinical status. (Journal of neuropsychology, 2026) — In a double-blind RCT with 120 chronic pain participants, both active tES modalities (M1-tDCS and DLPFC-tACS) significantly improved quality of life compared to sham, with mean differences of -7.7 and -7.8 respectively (p<.001). However, no differential effects were found for symptom-specific domains like mood, fatigue, or sleep, and all groups showed increased physical activity and physical function improvements.
How It Works
The proposed biological pathway:
- ▸tES modulates maladaptive nociplastic changes in chronic pain
- ▸Neuromodulation of motor cortex or prefrontal cortex alters pain processing
- ▸Improvements in QoL may arise from combined neurophysiological and contextual factors
- ▸Result: Enhanced QoL but no specific effects on mood, fatigue, or sleep
Who Might Benefit
Evidence fit by population:
- ▸120 individuals with chronic pain (97 females, mean age 49.5 ± 8.7 years)
Recommended Dose
15 sessions (frequency and duration per session not specified in abstract)
Limitations & Caveats
Important context when interpreting this evidence:
- ▸No differential effects on symptom-specific domains (mood, fatigue, sleep) compared to sham
- ▸All groups showed increased physical activity and physical function, suggesting strong contextual or placebo effects
- ▸Sample predominantly female (97 out of 120), limiting generalizability
Frequently Asked Questions
Did the active tES treatments improve pain directly?▼
The abstract focuses on QoL and physical function, not pain intensity; analgesic effects are mentioned as known but not specifically reported here.
Were there differences between tDCS and tACS in effectiveness?▼
No, both active modalities showed similar improvements in QoL (MD=-7.7 vs -7.8), with no significant differences between them.
Did the sham group also improve?▼
Yes, all groups (including sham) showed increased physical activity during intervention and improved physical function after intervention, indicating contextual factors contributed.
Is this treatment suitable for home use?▼
Yes, the study used home-based tES, suggesting it is feasible for self-administration under remote supervision.
References
- 1.Gil-Ugidos A, López-Corchón M, Τsiarleston G, Segura-Jiménez V, Carrillo-de-la-Peña MT. “Transcranial electric stimulation in chronic pain: Effects on quality of life, physical function, activity and clinical status..” Journal of neuropsychology, 2026. PMID: 42490298 DOI: 10.1111/jnp.70063